Showing results (231-240 of 433) with videos related to
Sort By:
Pageof 44
Circulation|August 20, 2003
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trialKenneth W Mahaffey, Christopher B Granger, Jose C Nicolau, et al.Journal of the American College of Cardiology|October 18, 2003
Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trialTimothy A Sanborn, Lynn A Sleeper, John G Webb, et al.Journal of the American College of Cardiology|September 10, 2025
Trajectories of Angina After Initial Invasive vs Conservative Strategy for Chronic Coronary DiseaseNobuhiro Ikemura, Philip G Jones, Zhuxuan Fu, et al.The American Journal of Cardiology|August 2, 2022
Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramNathaniel R Smilowitz, Evan P Carey, Binita Shah, et al.The American Journal of Cardiology|April 10, 2012
Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary proceduresNathaniel R Smilowitz, Ajay J Kirtane, Michael Guiry, et al.American Heart Journal|June 5, 2018
Telephone-based mindfulness training to reduce stress in women with myocardial infarction: Rationale and design of a multicenter randomized controlled trialTanya M Spruill, Harmony R Reynolds, Victoria Vaughan Dickson, et al.Circulation|August 13, 2003
Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shockEdmond W Chen, John G Canto, Lori S Parsons, et al.The Canadian Journal of Cardiology|April 3, 2019
Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS TrialPadma Kaul, Karen P Alexander, E Magnus Ohman, et al.European Heart Journal|June 9, 2009
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trialRenato D Lopes, Laine E Elliott, Harvey D White, et al.European Heart Journal. Acute Cardiovascular Care|April 22, 2015
Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trialHarvey D White, Cynthia M Westerhout, Karen P Alexander, et al.Pageof 44